MedTrace Logo

Precision Imaging to Evaluate Kaposi Sarcoma

NCT06898203 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2026-05-08

No results posted yet for this study

Summary

AIMS 2 \& 3:

In this study the investigators seek to formally compare reproducibility and accuracy of KS lesion size measurements between SkinScan3D and the current standard of care manual measurement method. The investigators will then test the SS3D device on 100 patients in a variety of real-world practice locations to determine whether the device will be usable, acceptable, appropriate, and feasible in routine care settings.

Conditions

  • Kaposi Sarcoma

Interventions

DEVICE

SkinScan3D

A handheld, simple, low-cost, and user-friendly technology that combines liquid lens technology and artificial intelligence (AI).

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Pensievision

    collaborator UNKNOWN

  • Kenya Medical Research Institute

    collaborator OTHER

  • Makerere University

    collaborator OTHER

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Thomas Odeny, MBChB, MPH, PhD · Washington University School of Medicine

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2028-11-30
Completion
2029-11-30

Countries

  • Kenya
  • Uganda

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06898203 on ClinicalTrials.gov